AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that William
Heiden, AMAG’s new chief executive officer, will present at two investor
conferences in June. The presentations will include a company overview
and a review of the company’s growth opportunities.
The presentations will take place as follows:
June 4, at 9:30 a.m. EDT – Jefferies 2012 Global Healthcare Conference
in New York City; and
June 6, at 2:40 p.m. PDT – Goldman Sachs 33rd Annual Global
Healthcare Conference in Rancho Palos Verdes, California.
A live webcast of each presentation will be accessible through the
Investors section of the company’s website at www.amagpharma.com.
Following the conferences, the webcasts will be archived on the AMAG
Pharmaceuticals, Inc. website for approximately two weeks.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company focused
on the development and commercialization of a therapeutic iron compound
to treat iron deficiency anemia. For additional company information,
please visit www.amagpharma.com.